See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Liberation Day
Natural Disasters
Donald Trump
Trade War
Social Media
Stock Markets
Trade
Artificial Intelligence
Nintendo
Climate Change
Taxes
Published • loading... • Updated

How researchers are shining a light on kidney disease

Summary by Science Daily
For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments. More than 12.4 million people worldwide suffer from the dominant form of the condition. Now, geneticists have uncovered fresh details of how the disease progresses -- findings that could open the door to new therapies.

4 Articles

All
Left
Center
2
Right
NatureNature
Center

Association between COVID-19 and the development of chronic kidney disease in patients without initial acute kidney injury

While the association between COVID-19 and acute kidney injury (AKI) is well documented, the impact of COVID-19 on the development of advanced chronic kidney disease (CKD) remains unclear, particularly in patients without initial AKI. Using the TriNetX healthcare database, we conducted a matched cohort study comparing 141,587 COVID-19 and 141,587 influenza patients. We excluded patients with AKI within one month of infection and matched groups o…

·United Kingdom
Read Full Article
Science DailyScience Daily
Center

How researchers are shining a light on kidney disease

For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments. More than 12.4 million people worldwide suffer from the dominant form of the condition. Now, geneticists have uncovered fresh details of how the disease progresses -- findings that could open the door to new therapies.

·United States
Read Full Article
European Pharmaceutical ManufacturerEuropean Pharmaceutical Manufacturer

Companies collaborate to discover and develop renal tissue-targeting drugs

MultiOmic Health and Alloy Therapeutics have announced they have signed a Memorandum of Understanding to jointly discover and develop first-in-class renal tissue-targeting drugs.

Read Full Article
Medical XpressMedical Xpress

New way to grow iPS cell-derived kidney progenitor cells may lead to renal regenerative therapies

Professor Kenji Osafune (Department of Cell Growth and Differentiation) and his team of researchers have devised an effective means to grow iPS cell-derived kidney progenitor cells, paving the way for renal regenerative therapies to become a reality. The findings are published in the journal Science Translational Medicine.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medical Xpress broke the news in on Thursday, April 3, 2025.
Sources are mostly out of (0)

Similar News Topics

Medical

Medical

Science

Science

Coronavirus

Coronavirus

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal